back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-04-03 10:10 Tx date 2025-03-31 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,000,000 vol |
||
| Filed 2025-04-02 18:51 Tx date 2025-03-31 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,000,000 vol |
||
| Filed 2025-04-02 18:51 Tx date 2025-03-31 |
$RVV
Revive Therapeutics Ltd. |
Chianelli, Fabio
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,000,000 vol |
2,000,000 | |
| Filed 2025-04-02 18:49 Tx date 2025-03-31 |
$RVV
Revive Therapeutics Ltd. |
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+700,000 vol |
1,850,000 | |
| Filed 2025-04-02 18:45 Tx date 2025-03-31 |
$RVV
Revive Therapeutics Ltd. |
Jackson, William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+700,000 vol |
2,100,000 | |
| Filed 2025-04-02 18:40 Tx date 2025-03-31 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,500,000 vol |
18,500,000 | |
| Filed 2025-04-02 13:38 Tx date 2025-03-31 |
$RVV
Revive Therapeutics Ltd. |
Lindzon, Andrew Stuart
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+700,000 vol |
1,850,000 | |
| Filed 2024-12-27 09:11 Tx date 2024-12-27 |
$RVV
Revive Therapeutics Ltd. |
Lindzon, Andrew Stuart
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-500,000 vol |
1,150,000 | |
| Filed 2024-12-27 08:53 Tx date 2024-12-27 |
$RVV
Revive Therapeutics Ltd. |
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-500,000 vol |
1,150,000 | |
| Filed 2024-12-27 08:49 Tx date 2024-12-27 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,500,000 vol |
15,000,000 | |
| Filed 2024-11-26 11:57 Tx date 2024-01-02 |
$RVV
Revive Therapeutics Ltd. |
Herman, Joshua Jonathan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,025,334 | |
| Filed 2024-11-26 11:56 Tx date 2024-06-21 |
$RVV
Revive Therapeutics Ltd. |
Herman, Joshua Jonathan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+750,000 vol |
1,775,334 | |
| Filed 2024-11-26 11:55 Tx date 2024-08-31 |
$RVV
Revive Therapeutics Ltd. |
Herman, Joshua Jonathan
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-125,334 vol |
1,650,000 | |
| Filed 2024-11-26 11:52 Tx date 2024-11-26 |
$RVV
Revive Therapeutics Ltd. |
Herman, Joshua Jonathan
4 - Director of Issuer
Holder: Carly Herman (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
-100,000 vol |
0 | |
| Filed 2024-10-29 16:16 Tx date 2024-01-31 |
$RVV
Revive Therapeutics Ltd. |
Marrelli, Carmelo
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-10,000 vol |
560,000 | |
| Filed 2024-07-11 14:14 Tx date 2024-07-10 |
$RVV
Revive Therapeutics Ltd. |
Lindzon, Andrew Stuart
4 - Director of Issuer
Holder: Aaron Lindzon (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,995
+333,000 vol $0.015 each |
433,000 | |
| Filed 2024-07-03 10:34 Tx date 2024-07-03 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+500,000 vol $0.01 each |
3,138,500 | |
| Filed 2024-03-19 19:28 Tx date 2024-03-19 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,500
+100,000 vol $0.035 each |
2,638,500 | |
| Filed 2024-03-18 10:16 Tx date 2024-03-18 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,250
+150,000 vol $0.035 each |
2,538,500 | |
| Filed 2024-03-15 16:30 Tx date 2024-03-15 |
$RVV
Revive Therapeutics Ltd. |
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$540.00
+18,000 vol $0.03 each |
2,388,500 |